Cargando…
Identification of Potential Druggable Targets and Structure-Based Virtual Screening for Drug-like Molecules against the Shrimp Pathogen Enterocytozoon hepatopenaei
Enterocytozoon hepatopenaei (EHP) causes slow growth syndrome in shrimp, resulting in huge economic losses for the global shrimp industry. Despite worldwide reports, there are no effective therapeutics for controlling EHP infections. In this study, five potential druggable targets of EHP, namely, aq...
Autores principales: | Paria, Prasenjit, Tassanakajon, Anchalee |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9867128/ https://www.ncbi.nlm.nih.gov/pubmed/36674953 http://dx.doi.org/10.3390/ijms24021412 |
Ejemplares similares
-
The emerging pathogen Enterocytozoon hepatopenaei drives a degenerative cyclic pattern in the hepatopancreas microbiome of the shrimp (Penaeus vannamei)
por: López-Carvallo, Jesús Antonio, et al.
Publicado: (2022) -
The microsporidian Enterocytozoon hepatopenaei is not the cause of white feces syndrome in whiteleg shrimp Penaeus (Litopenaeus) vannamei
por: Tangprasittipap, Amornrat, et al.
Publicado: (2013) -
Laboratory cohabitation challenge model for shrimp hepatopancreatic microsporidiosis (HPM) caused by Enterocytozoon hepatopenaei (EHP)
por: Salachan, Paul Vinu, et al.
Publicado: (2017) -
Integrated qPCR and Staining Methods for Detection and Quantification of Enterocytozoon hepatopenaei in Shrimp Litopenaeus vannamei
por: Wang, Lijun, et al.
Publicado: (2020) -
First Report of Enterocytozoon hepatopenaei Infection in Pacific Whiteleg Shrimp (Litopenaeus vannamei) Cultured in Korea
por: Kim, Bo-Seong, et al.
Publicado: (2021)